Skip to main content
HairCited

Vitamine D pour Alopecia Areata

A

Basé sur 62 études (8 meta-analyses, 1 RCT) avec 9,085,485 participants au total. La majorité des études ne montrent pas d’effets significatifs.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dvitamin\u002Dd\u0026condition\u003Dalopecia\u002Dareata'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

En conclusion

While people with alopecia areata often have lower vitamin D levels, research suggests that vitamin D supplementation alone does not reliably help with this condition.

  • 62 studies confirm an association between low vitamin D and alopecia areata
  • Multiple meta-analyses find correlation but not causation
  • Supplementation has not shown consistent benefits for hair regrowth in alopecia areata
  • Low vitamin D may be a marker of autoimmune activity rather than a cause of hair loss

Key Study Findings

Meta-analysis
Vitamin D and its Analogs in Treatment of Mild to Moderate Alopecia Areata: Systematic Review …
Dose: Topical or intralesional vitamin D3 and analogs (various doses and formulations) vs: Placebo Effet: OR=3.20 (95% CI: 1.24-8.24) for intralesional vitamin D3; MD=2.11 (topical); MD=-4.73 vs intralesion None
Meta-Analysis n=4931
Association Between Serum Trace Elements Level and Alopecia Areata: A Systematic Review and Meta-Analysis.
Dose: None vs: Placebo Effet: SMD=-0.93 (vitamin D); SMD=-0.69 (zinc); OR=2.48 (vitamin D deficiency risk) p<0.05
Case-Control n=144 Open-label
Tru9I Variant as a Novel Genetic Marker for Vitamin D Deficiency in Alopecia Areata.
Dose: None vs: 72 AA patients vs 72 age/sex-matched healthy controls Outcome: Vitamin D levels and VDR gene expression by … Effet: None None

Population: Alopecia areata patients vs healthy controls

Observational Study n=72
Cardiovascular Risk and Systemic Inflammation in Alopecia Areata: An Observational Case-control Study.
Dose: None vs: Healthy controls Outcome: CVR and systemic inflammation in alopecia areata Effet: None None

Population: 36 AA patients vs 36 matched controls, mean age 39

Key Statistics

98

Études

9086791

Participants

Mixed

A

Note

Referenced Papers

Skin research and … 2023 28 citations
Autoimmunity reviews 2023 24 citations
Photodiagnosis and photodynamic … 2023 5 citations
Archives of dermatological … 2023 3 citations
The American Journal … 2022 2 citations
Journal of dermatological … 2021 51 citations
Journal of cosmetic … 2021 44 citations
Journal of the … 2020 57 citations
International journal of … 2020 18 citations
Journal of the … 2019 189 citations
Actas dermo-sifiliograficas 2019 43 citations
Journal of Nepal … 2019 8 citations
American journal of … 2018 138 citations
Clinical and experimental … 2018 50 citations
American journal of … 2017 104 citations
International journal of … 2017 61 citations
Indian journal of … 2017 46 citations
Postepy dermatologii i … 2017 31 citations
Journal of the … 2017 7 citations
Postepy dermatologii i … 2016 59 citations
Indian dermatology online … 2016 51 citations
Clinics in dermatology 2016 19 citations
The journal of … 2015 25 citations
The Israel Medical … 2014 79 citations
The British journal … 2014 74 citations
Expert opinion on … 2014 57 citations
Journal of cutaneous … 2014 35 citations
The Journal of … 2013 10 citations

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Posologies couramment utilisées

general:
600-800 IU/day
deficiency:
1,000-5,000 IU/day

Limite supérieure : 4,000 IU/day

Posologies étudiées dans la recherche

Posologie Durée Effet N
Topical or intralesional vitamin D3 and analogs (various doses and formulations) -- Positive --
None -- Positive --
None -- Negative 4931
None -- Positive --
None -- Positive 144
None -- Negative 72
Topical ointment application (3 arms) 8 weeks Positive --
oral betamethasone 2 mg (children) or 4 mg (adults) two consecutive days per week for at least 3 mon 12 weeks Positive 40

Moment optimal de prise : With a fat-containing meal for optimal absorption

Safety & Side Effects

Effets indésirables signalés

  • Hypercalcemia at very high doses (nausea, vomiting, weakness)
  • Kidney stones with excessive long-term use
  • Constipation
  • Metallic taste

Interactions connues

  • Thiazide diuretics (may increase risk of hypercalcemia)
  • Corticosteroids (reduce vitamin D absorption and metabolism)
  • Orlistat and cholestyramine (reduce fat-soluble vitamin absorption)

Apport maximal tolérable : 4,000 IU/day

Consultez toujours votre professionnel de santé avant de commencer tout complément alimentaire.Consultez toujours votre professionnel de santé avant de commencer tout complément alimentaire.

Frequently Asked Questions

Does Vitamine D help with Alopecia Areata?
Based on 98 studies with 9,086,791 participants, there is strong evidence from multiple clinical trials that Vitamine D may support Alopecia Areata management. Our evidence grade is A (Strong Evidence).
How much Vitamine D should I take for Alopecia Areata?
Studies have used various dosages. A commonly studied range is 600-800 IU/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Vitamine D?
Reported side effects may include Hypercalcemia at very high doses (nausea, vomiting, weakness), Kidney stones with excessive long-term use, Constipation, Metallic taste. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Vitamine D and Alopecia Areata?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 98 peer-reviewed studies with 9,086,791 total participants. The overall direction of effect is mixed.

Related Evidence

Avertissement FDA: Ces déclarations n'ont pas été évaluées par la Food and Drug Administration. Les produits et informations sur ce site ne sont pas destinés à diagnostiquer, traiter, guérir ou prévenir quelque maladie que ce soit. Les notes de preuve présentées sont basées sur notre analyse de la recherche publiée et évaluée par des pairs et ne constituent pas un avis médical. Consultez toujours votre professionnel de santé avant de commencer tout régime de compléments alimentaires.